Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Short term Debt (2022 - 2026)

Exagen filings provide 5 years of Short term Debt readings, the most recent being $580000.0 for Q1 2026.

  • On a quarterly basis, Short term Debt fell 77.12% to $580000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $580000.0, a 77.12% decrease, with the full-year FY2025 number at $643000.0, up 52.01% from a year prior.
  • Short term Debt hit $580000.0 in Q1 2026 for Exagen, down from $643000.0 in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $2.5 million in Q1 2025 to a low of $190000.0 in Q4 2022.
  • Median Short term Debt over the past 5 years was $423000.0 (2024), compared with a mean of $562500.0.
  • Biggest five-year swings in Short term Debt: surged 845.9% in 2025 and later plummeted 77.12% in 2026.
  • Exagen's Short term Debt stood at $190000.0 in 2022, then soared by 38.95% to $264000.0 in 2023, then soared by 60.23% to $423000.0 in 2024, then soared by 52.01% to $643000.0 in 2025, then dropped by 9.8% to $580000.0 in 2026.
  • The last three reported values for Short term Debt were $580000.0 (Q1 2026), $643000.0 (Q4 2025), and $680000.0 (Q3 2025) per Business Quant data.